Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown
Shuntaro Ogura, … , Yuichiro Ogura, Akiyoshi Uemura
Shuntaro Ogura, … , Yuichiro Ogura, Akiyoshi Uemura
Published February 9, 2017
Citation Information: JCI Insight. 2017;2(3):e90905. https://doi.org/10.1172/jci.insight.90905.
View: Text | PDF
Research Article Ophthalmology Vascular biology

Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown

  • Text
  • PDF
Abstract

In the central nervous system, endothelial cells (ECs) and pericytes (PCs) of blood vessel walls cooperatively form a physical and chemical barrier to maintain neural homeostasis. However, in diabetic retinopathy (DR), the loss of PCs from vessel walls is assumed to cause breakdown of the blood-retina barrier (BRB) and subsequent vision-threatening vascular dysfunctions. Nonetheless, the lack of adequate DR animal models has precluded disease understanding and drug discovery. Here, by using an anti-PDGFRβ antibody, we show that transient inhibition of the PC recruitment to developing retinal vessels sustained EC-PC dissociations and BRB breakdown in adult mouse retinas, reproducing characteristic features of DR such as hyperpermeability, hypoperfusion, and neoangiogenesis. Notably, PC depletion directly induced inflammatory responses in ECs and perivascular infiltration of macrophages, whereby macrophage-derived VEGF and placental growth factor (PlGF) activated VEGFR1 in macrophages and VEGFR2 in ECs. Moreover, angiopoietin-2 (Angpt2) upregulation and Tie1 downregulation activated FOXO1 in PC-free ECs locally at the leaky aneurysms. This cycle of vessel damage was shut down by simultaneously blocking VEGF, PlGF, and Angpt2, thus restoring the BRB integrity. Together, our model provides new opportunities for identifying the sequential events triggered by PC deficiency, not only in DR, but also in various neurological disorders.

Authors

Shuntaro Ogura, Kaori Kurata, Yuki Hattori, Hiroshi Takase, Toshina Ishiguro-Oonuma, Yoonha Hwang, Soyeon Ahn, Inwon Park, Wataru Ikeda, Sentaro Kusuhara, Yoko Fukushima, Hiromi Nara, Hideto Sakai, Takashi Fujiwara, Jun Matsushita, Masatsugu Ema, Masanori Hirashima, Takashi Minami, Masabumi Shibuya, Nobuyuki Takakura, Pilhan Kim, Takaki Miyata, Yuichiro Ogura, Akiyoshi Uemura

×

Figure 3

Irreversible retinal vascular dysfunctions after transient PDGFRβ inhibition.

Options: View larger image (or click on image) Download as PowerPoint
Irreversible retinal vascular dysfunctions after transient PDGFRβ inhibi...
(A) IHC for CD31 and desmin in the 3 vascular layers of 4-week retinas (related to Figure 2A). (B) Quantification of diameters of arteries (n = 10), veins (n = 10), and capillaries (n = 50) in the superficial vessels of 4-week retinas. (C and D) IHC for CD31 and α-smooth muscle actin (αSMA) in 4-week retinas. Lower panels in C are magnified views of the boxed areas (veins) in the upper panels. Note the αSMA upregulation in venous and capillary pericytes (PCs), and their dissociation from the vessel walls in the APB5-treated retinas. (E) Scanning electron microscopy of 4-week retinal veins. (F) Labeling for CD31, Ets-related gene-1 (ERG1), and 5-ethynyl-2′-deoxyuridine (EdU, upper), and for CD31 (lower) in 4-week retinas. The graphs show the number of proliferating endothelial cells (ECs) per retina (control, n = 6; APB5, n = 8) and sprouting ECs with filopodia projections per retina (n = 10). (G) IHC for CD31 combined with cleaved caspase-3 (upper) or type IV collagen (Col IV; lower) in 4-week retinas. Note the ghost vessels represented by basement membrane sleeves without EC linings in the APB5-treated retina. The graphs show the number of apoptotic ECs per retina (n = 4) and ghost vessels per area (n = 16). (H) Sequential monitoring of fluorescein angiography in the same retinal area. Note the continuous vascular remodeling without resolving nonperfusion. (I) IHC for CD31 and biotin after biotin perfusion in 4-week retinas. (J) IHC for vascular endothelial cadherin (VE-cad), ERG1, and claudin-5 in 4-week retinal veins. (K) IHC for CD31 and plasmalemma vesicle–associated protein (PLVAP) in 4-week retinas. (L) Transmission electron microscopy after biotin perfusion in 4-week retinas. Note the deposition of electron-dense tracers in disrupted EC junctions (arrowheads) and intracellular vesicles (arrows). Asterisks indicate vessel lumen. *P < 0.05, **P < 0.01, ***P < 0.001 (2-tailed Student’s t test). Scale bars: 100 μm (A, C upper, I, and K); 50 μm (C lower, D, F upper, and G); 5 μm (E, F lower, J, and L).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts